Quantitative Investment Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $513K | Sell |
23,601
-40,069
| -63% | -$776K | 0.05% | 285 |
|
|
2025
Q4 | $1.37M | Buy |
+63,670
| New | +$1.34M | 0.13% | 165 |
|
|
2025
Q3 | – | Sell |
-32,237
| Closed | -$551K | – | 482 |
|
|
2025
Q2 | $551K | Buy |
+32,237
| New | +$1.38M | 0.07% | 192 |
|
|
2024
Q3 | – | Sell |
-10,766
| Closed | -$1.7M | – | 429 |
|
|
2024
Q2 | $1.7M | Buy |
+10,766
| New | +$1.38M | 0.19% | 104 |
|
|
2023
Q1 | – | Sell |
-5,510
| Closed | -$713K | – | 312 |
|
|
2022
Q4 | $713K | Buy |
+5,510
| New | +$639K | 0.14% | 124 |
|
|
2022
Q2 | – | Sell |
-10,860
| Closed | -$848K | – | 303 |
|
|
2022
Q1 | $848K | Buy |
10,860
+759
| +8% | +$58.1K | 0.09% | 115 |
|
|
2021
Q4 | $909K | Buy |
+10,101
| New | +$864K | 0.13% | 136 |
|
|
2021
Q2 | – | Sell |
-23,171
| Closed | -$1.73M | – | 572 |
|
|
2021
Q1 | $1.73M | Sell |
23,171
-20,044
| -46% | -$1.85M | 0.15% | 173 |
|
|
2020
Q4 | $7.37M | Buy |
+43,215
| New | +$6.4M | 0.6% | 34 |
|
|
2020
Q2 | – | Sell |
-2,290
| Closed | -$224K | – | 676 |
|
|
2020
Q1 | $224K | Buy |
+2,290
| New | +$262K | 0.02% | 434 |
|
|
2019
Q3 | – | Sell |
-68,203
| Closed | -$10.4M | – | 757 |
|
|
2019
Q2 | $10.4M | Buy |
+68,203
| New | +$8.29M | 0.4% | 57 |
|
|
2018
Q2 | – | Sell |
-144,500
| Closed | -$10.7M | – | 915 |
|
|
2018
Q1 | $10.7M | Buy |
144,500
+77,100
| +114% | +$5.14M | 0.19% | 131 |
|
|
2017
Q4 | $3.75M | Sell |
67,400
-236,700
| -78% | -$12.5M | 0.06% | 378 |
|
|
2017
Q3 | $13.8M | Buy |
304,100
+149,700
| +97% | +$5.98M | 0.16% | 165 |
|
|
2017
Q2 | $5.2M | Buy |
+154,400
| New | +$5.03M | 0.08% | 323 |
|
|
2017
Q1 | – | Sell |
-197,400
| Closed | -$5.41M | – | 892 |
|
|
2016
Q4 | $5.41M | Buy |
+197,400
| New | +$7.93M | 0.14% | 222 |
|
|
2016
Q3 | – | Sell |
-167,800
| Closed | -$3.2M | – | 853 |
|
|
2016
Q2 | $3.2M | Buy |
+167,800
| New | +$3.11M | 0.15% | 203 |
|
|
2016
Q1 | – | Sell |
-11,400
| Closed | -$439K | – | 921 |
|
|
2015
Q4 | $439K | Sell |
11,400
-6,000
| -34% | -$195K | 0.03% | 521 |
|
|
2015
Q3 | $558K | Buy |
17,400
+9,100
| +110% | +$309K | 0.04% | 421 |
|
|
2015
Q2 | $252K | Buy |
+8,300
| New | +$170K | 0.04% | 348 |
|
|
2013
Q4 | – | Sell |
-16,700
| Closed | -$788K | – | 705 |
|
|
2013
Q3 | $788K | Buy |
16,700
+11,000
| +193% | +$424K | 0.07% | 258 |
|
|
2013
Q2 | $216K | Buy |
+5,700
| New | +$204K | 0.04% | 385 |
|
Other funds holding SRPT
VPM
VCM
RCM
EAM
Quantitative Investment Management's SRPT Position: Q1 2026 in Review
Quantitative Investment Management reduced its Sarepta Therapeutics (SRPT) stake by 63% in Q1 2026, selling an estimated $776K and leaving 23,601 shares worth $513K. The position accounts for 0.05% of the portfolio, ranked #285.
Quantitative Investment Management first reported a position in SRPT in Q2 2013 and has held it in 22 quarters since. The position peaked at $13.8M in Q3 2017. 340 funds tracked by Wall St. Rank hold SRPT as of Q1 2026.
- Quantitative Investment Management held 23,601 shares of Sarepta Therapeutics worth $513K as of Q1 2026.
- Quantitative Investment Management sold 40,069 Sarepta Therapeutics shares in Q1 2026, an estimated $776K.
- Sarepta Therapeutics made up 0.05% of Quantitative Investment Management's portfolio in Q1 2026, its #285 holding.
- Quantitative Investment Management first reported a position in Sarepta Therapeutics in Q2 2013 and has held it in 22 quarters since.
- Quantitative Investment Management's Sarepta Therapeutics position peaked at $13.8M in Q3 2017.
- 340 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2026.
Based on Quantitative Investment Management's 13F filing for Q1 2026, filed 15 May 2026.